Mirum Pharmaceuticals Inc... (MIRM)
45.06
-0.93 (-2.02%)
At close: Mar 31, 2025, 3:59 PM
44.55
-1.14%
After-hours: Mar 31, 2025, 07:56 PM EDT
Mirum Pharmaceuticals Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Cash & Equivalents | 222.5M | 286.33M | 28M | 31.34M | 142.09M | 139.95M | 51.96M |
| Short-Term Investments | 57.81M | n/a | 123.72M | 125.2M | 89.73M | 104.69M | n/a |
| Long-Term Investments | 12.53M | n/a | 100M | 4.98M | n/a | 23.29M | n/a |
| Other Long-Term Assets | 5.81M | 4.17M | 101.38M | 101.79M | 1.27M | 324K | n/a |
| Receivables | 78.29M | 67.97M | 23.99M | 3.27M | n/a | n/a | n/a |
| Inventory | 22.4M | 22.31M | 5.57M | 1.51M | n/a | n/a | n/a |
| Other Current Assets | 11.78M | 10.94M | 8.95M | 10.54M | 9.06M | 5.41M | 24K |
| Total Current Assets | 392.79M | 387.54M | 190.22M | 166.59M | 236.35M | 119.36M | 51.98M |
| Property-Plant & Equipment | 9.81M | 1.99M | 2.35M | 2.55M | 3.24M | 3.73M | n/a |
| Goodwill & Intangibles | 249.82M | 252.93M | 58.95M | 18.74M | n/a | n/a | n/a |
| Total Long-Term Assets | 277.97M | 259.08M | 162.68M | 128.06M | 4.51M | 27.35M | n/a |
| Total Assets | 670.75M | 646.62M | 352.91M | 294.65M | 240.86M | 146.71M | 51.98M |
| Account Payables | 14.62M | 7.42M | 8.69M | 9.17M | 3.15M | 3.35M | 269K |
| Deferred Revenue | n/a | n/a | n/a | 30.72M | 13.41M | n/a | n/a |
| Short-Term Debt | 1.71M | 1.1M | 1.86M | 1.42M | 1.27M | 794K | n/a |
| Other Current Liabilities | 110.22M | 78.54M | 54.18M | 32.01M | 14.04M | 8.93M | 2.18M |
| Total Current Liabilities | 126.55M | 87.06M | 64.73M | 42.6M | 18.46M | 13.08M | 2.45M |
| Long-Term Debt | 316.05M | 307.04M | 2.51M | 3.81M | 5.25M | 6.5M | n/a |
| Other Long-Term Liabilities | 2.51M | 3.85M | 143.63M | 128.04M | 45.05M | -3.21M | 59.85M |
| Total Long-Term Liabilities | 318.56M | 310.89M | 146.14M | 131.84M | 50.31M | 3.29M | 59.85M |
| Total Liabilities | 445.11M | 397.95M | 210.87M | 174.44M | 68.77M | 16.36M | 62.3M |
| Total Debt | 317.76M | 308.14M | 2.19M | 2.61M | 3.26M | 3.65M | n/a |
| Common Stock | 5K | 5K | 4K | 3K | 3K | 2K | 6.99M |
| Retained Earnings | -644.18M | -556.24M | -392.82M | -257.16M | -173.17M | -69.9M | -17.35M |
| Comprehensive Income | -373K | 1.64M | -217K | -35K | 83K | 129K | -66.84M |
| Shareholders Equity | 225.64M | 248.67M | -392.82M | 120.21M | -173.17M | -69.9M | -10.32M |
| Total Investments | 70.34M | n/a | 123.72M | 130.18M | 89.73M | 127.98M | n/a |